中国呼吸与危重监护杂志

中国呼吸与危重监护杂志

降钙素原在肺部感染诊治中的价值

查看全文

引用本文: 王健珍, 曹大伟, 张新日. 降钙素原在肺部感染诊治中的价值. 中国呼吸与危重监护杂志, 2018, 17(4): 435-438. doi: 10.7507/1671-6205.201801019 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
1. Becker KL, Nylén ES, White JC, et al. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab, 2004, 89(4): 1512.
2. Alnakeeb S, Clermont G. Procalcitonin testing has the potential to reduce unnecessary antibiotic use in patients with suspected lower respiratory tract infections. Crit Care, 2005, 9(3): 1-2.
3. Russwurm S, Stonans I, Stonane E, et al. Procalcitonin and CGRP-1 mrna expression in various human tissues. Shock, 2001, 16(2): 109.
4. Linscheid P, Seboek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology, 2003, 144(12): 5578-5584.
5. Linscheid P, Seboek D, Schaer DJ, et al. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Criti Care Med, 2004, 32(8): 1715.
6. Müller B, White JC, Nylén ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab, 2001, 86(1): 396.
7. Hatzistilianou M. Diagnostic and prognostic role of procalcitonin in infections. ScientificWorldJournal, 2010, 10(1): 1941-1946.
8. Meisner M, Lohs T, Huettemann E, et al. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol., 2001, 18(2): 79-87.
9. 张德文, 刘勇, 龙林会, 童玲. 血清 PCT 检测对慢性肾衰竭患者合并细菌感染的临床应用价值. 实用医院临床杂志, 2017, 14(03): 59-61.
10. 陶瑾, 申新宏, 艾永红, 等. 血清 PCT 在患者腹膜透析感染性腹膜炎中的诊断价值. 中华医院感染学杂志, 2015, 25(16): 3610-3612.
11. 高慧, 吕利明, 张晓华, 等. 透析感染患者血浆 PCT 和 C-反应蛋白的比较研究. 中华医院感染学杂志, 2016, 26(19): 4404-4406.
12. Tavares E, Miñano FJ. Immunoneutralization of the aminoprocalcitonin peptide of procalcitonin protects rats from lethal endotoxaemia: neuroendocrine and systemic studies. Clin Sci (Lond), 2010, 119(12): 519-534.
13. Sexton PM, Christopoulos G, Christopoulos A, et al. Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis. Crit Care Med, 2008, 36(36): 1637-1640.
14. Araujo M, DoiSQ, Palant CE, et al. Procalcitonin induced cytotoxicity and apoptosis in mesangial cells: implications for septic renal injury. Inflamm Res, 2013, 62(10): 887-894.
15. van Vugt SF, Broekhuizen BD, Lammens C, et al. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ 2013, 346(30): f2450.
16. Holm A, Pedersen SS, Nexoe J, et al. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract, 2007, 57(540): 555-560.
17. Andreeva E, Melbye H. Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomized clinical trial with C-reactive protein testing in the intervention group. BMC Fam Pract, 2014, 15(1): 80.
18. 尹义平, 胡苏萍, 杨澄清, 等. PCT 在细菌性肺炎及肺结核中的鉴别研究. 临床肺科杂志, 2013, 18(5): 786-788.
19. Haeuptle J, Zaborsky R, Fiumefreddo R, et al. Prognostic value of procalcitonin in Legionella pneumonia. Eur J Clin Microbiol Infect Dis, 2009, 28(1): 55-60.
20. 李艳红, 张霞, 郭秋野. C 反应蛋白联合 PCT 检测在老年社区获得性肺炎中应用 126 例临床观察. 实用临床医药杂志, 2012, 16(17): 135-137.
21. Wu CW, Wu JY, Chen CK, et al. Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis. Support Care Cancer, 2015, 23(10): 2863-2872.
22. 向攀, 赵红心, 王芳, 等. 肾综合征出血热患者 PCT 测定的临床价值 中华实验和临床感染病杂志: 电子版, 2015, 9(6): 28-30.
23. Jereb M, Lunaček NK, Kotar T, et al. Procalcitonin in hantavirus infections. Scand J Clin Lab Inves, 2011, 71(4): 287-291.
24. Hoenigl M, Raggam RB, Wagner J, et al. Procalcitonin fails to predict bacteremia in SIRS patients: a cohort study. Int J Clin Pract, 2014, 68(10): 1278-1281.
25. Yu Y, Li XX, Jiang LX, et al. Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study. Infect Dis, 2016, 48(1): 63-69.
26. Riedel S, Melendez JH, An AT, et al. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol, 2011, 135(2): 182-189.
27. Zhao Y, Li C, Jia Y. Evaluation of the Mortality in Emergency Department Sepsis score combined with procalcitonin in septic patients. Am J Emerg Med, 2013, 31(7): 1086.
28. 韩忠学, 刘静, 巩静. 降钙素原在鲍曼不动杆菌定植与感染鉴别中的应用. 国际检验医学杂志, 2017, 38(3): 407-408.
29. 任红梅. 血清炎性指标对血流感染患者感染病原菌早期鉴别诊断的价值. 国际检验医学杂志, 2016, 37(10): 1373-1374.
30. Guo S Y, Zhou Y, Hu Q F, et al. Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis. Am J Med Sci, 2015, 349(6): 499-504.
31. Maisel A, Neath S X, Landsberg J, et al. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Heart Fail, 2012, 14(3): 278-286.
32. Demissei BG, Cleland JG, O'Connor CM, et al. Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients. Int J Cardiol, 2016, 204: 164-171.
33. Schuetz P, Kutz A, Grolimund E, et al. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial. Int J Cardiol, 2014, 175(3): 464-472.
34. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections Eur Respir J, 2011, 17 Suppl 6(s6): 1.
35. PCT 急诊临床应用专家共识组. PCT(PCT) 急诊临床应用的专家共识. 中华急诊医学杂志, 2012, 21(9): 944-951.
36. Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev, 2017, 10: CD007498.
37. Nora D, Salluh J, Martin-Loeches I, et al. Biomarker-guided antibiotic therapy-strengths and limitations. Ann Transl Med, 2017, 5(10): 208.
38. Dusemund F, Bucher B, Meyer S, et al. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. Eur J Clin Microbiol Infect Dis, 2013, 32(1): 51-60.
39. Balk R A, Bozzette S A, Cao Z, et al. Effect of Procalcitonin Testing on Healthcare Utilization and Costs in Critically Ill Patients in the United States. Chest, 2016, 151(1).
40. Caspar C, Markus F, Andreas F B, et al. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis, 2016, 11(Issue 1): 1381-1389.
41. Kasamatsu Y, Yamaguchi T, Kawaguchi T, et al. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia. Respirology, 2012, 17(2): 330-336.
42. Schuetz P, Suterwidmer I, Chaudri A, et al. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J, 2011, 37(2): 384-392.
43. 徐冲, 董丽霞, 曹洁. PCT 在社区获得性肺炎预后评估中的价值. 中国呼吸与危重监护杂志, 2017(2): 117-121.
44. Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis, 2013, 13(5): 426-435.
45. Schuetz P, Raad I, Amin DN. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Curr Opin Crit Care, 2013, 19(5): 453-460.